Page 38 - BH-2-4

Brain & Heart Neurologic manifestations of IBD

of IBD. Early recognition and appropriate management 3. Benavente L, Morís G. Neurologic disorders associated with
of neurological symptoms can significantly improve inflammatory bowel disease. Eur J Neurol. 2011;18(1):138-143.
patient outcomes. Moreover, ongoing research into the doi: 10.1111/j.1468-1331.2010.03095.x
mechanisms linking IBD with neurological complications
will be vital for developing more effective strategies for 4. Lossos A, River Y, Eliakim A, Steiner I. Neurologic
aspects of inflammatory bowel disease. Neurology.
prevention and treatment. 1995;45(3 Pt 1):416-421.
Ultimately, enhancing our understanding of the doi: 10.1212/wnl.45.3.416
neurological manifestations of IBD will lead to more
comprehensive care strategies, which reduce the burden of 5. Morís G. Inflammatory bowel disease: An increased risk
factor for neurologic complications. World J Gastroenterol.
these complications on patients and improve their overall 2014;20(5):1228-1237.
quality of life. As such, continued interdisciplinary research
collaboration is essential to advance our knowledge and doi: 10.3748/wjg.v20.i5.1228
improve the techniques used in managing patients with 6. Elsehety A, Bertorini TE. Neurologic and neuropsychiatric
these complications. complications of Crohn’s disease. South Med J.
1997;90(6):606-610.
Acknowledgments
doi: 10.1097/00007611-199706000-00005
None.
7. Sassi SB, Kallel L, Ben Romdhane S, Boubaker J, Filali A,
Funding Hentati F. Peripheral neuropathy in inflammatory bowel
disease patients: A prospective cohort study. Scand J
None. Gastroenterol. 2009;44(10):1268-1269.
Conflict of interest doi: 10.1080/00365520903199871
8. Oliveira GR, Teles BCV, Brasil EF, et al. Peripheral
The authors declare they have no competing interests. neuropathy and neurological disorders in an unselected
Author contributions Brazilian population-based cohort of IBD patients. Inflamm
Bowel Dis. 2008;14(3):389-395.
Conceptualization: Manjeet Kumar Goyal, Ashita Rukmini doi: 10.1002/ibd.20304
Vuthaluru
Writing–original draft: Manjeet Kumar Goyal, Ashita 9. Geissler A, Andus T, Roth M, et al. Focal white-matter
lesions in brain of patients with inflammatory bowel disease.
Rukmini Vuthaluru Lancet. 1995;345(8954):897-898.
Writing–review & editing: Shivam Kalra, Abhinav Rao,
Abhinav Gupta, Manisha Khubber doi: 10.1016/s0140-6736(95)90013-6
10. Zikou AK, Kosmidou M, Astrakas LG, Tzarouchi LC,
Ethics approval and consent to participate Tsianos E, Argyropoulou MI. Brain involvement in
Not applicable. patients with inflammatory bowel disease: A voxel-based
morphometry and diffusion tensor imaging study. Eur
Consent for publication Radiol. 2014;24(10):2499-2506.
Not applicable. doi: 10.1007/s00330-014-3242-6
11. Singh A, Goyal MK, Midha V, et al. Tofacitinib in acute
Availability of data severe ulcerative colitis (TACOS): A randomized controlled
Not applicable. trial. Am Coll Gastroenterol. 2024;119:1365-1372.
doi: 10.14309/ajg.0000000000002635
References
12. Bonaz BL, Bernstein CN. Brain-Gut interactions
1. Ott C, Schölmerich J. Extraintestinal manifestations and in inflammatory bowel disease. Gastroenterology.
complications in IBD. Nat Rev Gastroenterol Hepatol. 2013;144(1):36-49.
2013;10(10):585-595.
doi: 10.1053/j.gastro.2012.10.003
doi: 10.1038/nrgastro.2013.117
13. Ferro JM, Oliveira SN, Correia L. Neurologic manifestations
2. Ferro JM, Oliveira Santos M. Neurology of inflammatory of inflammatory bowel diseases. Handb Clin Neurol.
bowel disease. J Neurol Sci. 2021;424:117426. 2014;120:595-605.
doi: 10.1016/j.jns.2021.117426 doi: 10.1016/B978-0-7020-4087-0.00040-1

Volume 2 Issue 4 (2024) 9 doi: 10.36922/bh.3486